The opportunity of data-driven health services research to improve cancer outcomes | Prof Maarten IJzerman
Recent achievements in the Cancer Health Services Research group of the UMCCR, enabling the use of clinical and administrative data registries to optimise cancer outcomes.
Professor Maarten IJzerman
Head of Cancer Health Services Research
Melbourne School of Population and Global Health
University of Melbourne Centre for Cancer Research
This presentation will cover recent achievements in the Cancer Health Services Research group of the UMCCR, enabling the use of clinical and administrative data registries to optimise cancer outcomes.
The presentation includes recent work on identifying poorer outcomes by mapping treatment patterns and clinical trial participation in several metastatic cancers, the challenge for health systems to routinely use complex genomic testing, and the potential of simulation modelling optimise care delivery such as recently demonstrated in a study estimating collateral damage from COVID-19 induced care interruptions.
Professor IJzerman will specifically talk about two recently awarded projects, the PRECEPT project aiming to investigate patient preferences to support treatment decisions in localised prostate cancer and the PRIMCAT project, mapping the uptake and economic impact of new cancer treatments, including the use of histology independent cancer drugs for NTRK and MSI-H.
Professor Maarten J. IJzerman is the VCCC professor and head of Cancer Health Services Research (2018) in the University of Melbourne, Centre for Cancer Research and Centre for Health Policy. He also holds a fractional professorial appointment in the University of Twente in the Netherlands. Maarten is leading a global research team aiming to advance cancer outcomes and improve access to health service delivery. The research program is based on the use of real-world (linked) data for health services research, including the use of simulation models for clinical use of genomics and precision oncology.
Maarten has held leadership roles as the CEO of a rehabilitation research institute (2000-2007), scientific director and vice-dean for Biomedical Engineering and Technical Medicine (2014-2017) in the University of Twente. He has been a board member in two hospitals (MÃ xima Medisch Centrum and Radiotherapiegroep) in the Netherlands responsible for quality, innovation and information technology (2011-2019).